BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25563600)

  • 1. Host-pathogen interactome analysis of Chikungunya virus envelope proteins E1 and E2.
    Dudha N; Rana J; Rajasekharan S; Gabrani R; Gupta A; Chaudhary VK; Gupta S
    Virus Genes; 2015 Apr; 50(2):200-9. PubMed ID: 25563600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
    Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle.
    Torii S; Orba Y; Sasaki M; Tabata K; Wada Y; Carr M; Hobson-Peters J; Hall RA; Takada A; Fukuhara T; Matsuura Y; Hall WW; Sawa H
    J Biol Chem; 2020 Jun; 295(23):7941-7957. PubMed ID: 32341071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidic pH-Induced Conformational Changes in Chikungunya Virus Fusion Protein E1: a Spring-Twisted Region in the Domain I-III Linker Acts as a Hinge Point for Swiveling Motion of Domains.
    Sahoo B; Gudigamolla NK; Chowdary TK
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry.
    Sahoo B; Chowdary TK
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31167876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
    Tong W; Yin XX; Lee BJ; Li YG
    Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational analysis of human host binding partners of chikungunya and dengue viruses during coinfection.
    Ghildiyal R; Gabrani R
    Pathog Dis; 2021 Oct; 79(8):. PubMed ID: 34550340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of Chikungunya virus enhance fitness in Aedes aegypti.
    Agarwal A; Sharma AK; Sukumaran D; Parida M; Dash PK
    Virology; 2016 Oct; 497():59-68. PubMed ID: 27423270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary analysis of the Chikungunya virus epidemic in Mexico reveals intra-host mutational hotspots in the E1 protein.
    Muñoz-Medina JE; Garcia-Knight MA; Sanchez-Flores A; Monroy-Muñoz IE; Grande R; Esbjörnsson J; Santacruz-Tinoco CE; González-Bonilla CR
    PLoS One; 2018; 13(12):e0209292. PubMed ID: 30550577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component.
    Bouraï M; Lucas-Hourani M; Gad HH; Drosten C; Jacob Y; Tafforeau L; Cassonnet P; Jones LM; Judith D; Couderc T; Lecuit M; André P; Kümmerer BM; Lotteau V; Desprès P; Tangy F; Vidalain PO
    J Virol; 2012 Mar; 86(6):3121-34. PubMed ID: 22258240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
    Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
    Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Molecular Surveillance of Chikungunya Virus.
    Fischer C; de Lamballerie X; Drexler JF
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.
    Kumar P; Pok KY; Tan LK; Angela C; Leo YS; Ng LC
    J Virol Methods; 2014 Sep; 206():67-75. PubMed ID: 24880071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.
    Mahish C; De S; Chatterjee S; Ghosh S; Keshry SS; Mukherjee T; Khamaru S; Tung KS; Subudhi BB; Chattopadhyay S; Chattopadhyay S
    Front Immunol; 2023; 14():1139808. PubMed ID: 37153546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
    Weber C; Büchner SM; Schnierle BS
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003684. PubMed ID: 25905779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chikungunya virus adaptation to a mosquito vector correlates with only few point mutations in the viral envelope glycoprotein.
    Arias-Goeta C; Moutailler S; Mousson L; Zouache K; Thiberge JM; Caro V; Rougeon F; Failloux AB
    Infect Genet Evol; 2014 Jun; 24():116-26. PubMed ID: 24681263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characterization of chikungunya viruses isolated during the 2015-2017 outbreaks in different states of India, based on their E1 and E2 genes.
    Patil J; More A; Patil P; Jadhav S; Newase P; Agarwal M; Amdekar S; Raut CG; Parashar D; Cherian SS
    Arch Virol; 2018 Nov; 163(11):3135-3140. PubMed ID: 30073419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.